We are live on ! Find out more
FCM

Farallon Capital Management Portfolio holdings

AUM $17.5B
1-Year Est. Return 50.95%
This Fund
S&P 500
This Quarter Est. Return
+13.5%
1 Year Est. Return
+50.95%
3 Year Est. Return
+148.38%
5 Year Est. Return
+206.05%
10 Year Est. Return
+1,475.31%
AUM
$21.9B
AUM Growth
+$430M
Cap. Flow
-$2.03B
Cap. Flow %
-9.27%
Top 10 Hldgs %
51.69%
Holding
190
New
27
Increased
30
Reduced
39
Closed
32

Top Buys

Rank Stock Value
1
PXD
Pioneer Natural Resource Co.
PXD
+$731M
2
HES
Hess
HES
+$436M
3
NDAQ icon
Nasdaq
NDAQ
+$341M
4
SPLK
Splunk Inc
SPLK
+$157M
5
UTHR icon
United Therapeutics
UTHR
+$110M

Top Sells

Rank Stock Value
1
ATVI
Activision Blizzard
ATVI
+$1.9B
2
VMW
VMware, Inc
VMW
+$915M
3
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
+$770M
4
SGEN
Seagen Inc. Common Stock
SGEN
+$482M
5
AON icon
Aon
AON
+$216M

Sector Composition

Rank Sector Weight
1 Healthcare 27.49%
2 Technology 11.1%
3 Financials 9.67%
4 Industrials 6.16%
5 Communication Services 5.57%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AMED
51
DELISTED
Amedisys
AMED
$65.2M 0.3%
686,000
+262,000
+62% +$24.5M
CTLT
52
DELISTED
CATALENT, INC.
CTLT
$63.5M 0.29%
+1,413,000
New +$57.2M
PACB icon
53
Pacific Biosciences
PACB
$370M
$60.7M 0.28%
6,191,370
-4,032,750
-39% -$33M
HUM icon
54
Humana
HUM
$46.2B
$55.6M 0.25%
121,344
-243,117
-67% -$120M
BABA icon
55
Alibaba
BABA
$308B
$41.5M 0.19%
535,000
-327,233
-38% -$26.1M
PCG icon
56
PG&E
PCG
$38.5B
$41M 0.19%
2,271,642
-1,950,000
-46% -$32.9M
COR icon
57
Cencora
COR
$61.2B
$34.7M 0.16%
+169,000
New +$33M
BHVN icon
58
Biohaven
BHVN
$2.21B
$32.1M 0.15%
750,000
– –
SVRA icon
59
Savara
SVRA
$1.19B
$29.4M 0.13%
6,255,406
-4,652,680
-43% -$17.8M
THC icon
60
Tenet Healthcare
THC
$21.1B
$28.3M 0.13%
374,842
-655,158
-64% -$41.5M
IMGN
61
DELISTED
Immunogen Inc
IMGN
$25M 0.11%
+842,000
New +$16.8M
CERE
62
DELISTED
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
$24.1M 0.11%
+567,321
New +$16.3M
VRTX icon
63
Vertex Pharmaceuticals
VRTX
$126B
$22.4M 0.1%
55,000
-147,000
-73% -$54.3M
OPCH icon
64
Option Care Health
OPCH
$3.56B
$19.1M 0.09%
567,800
-294,200
-34% -$9.04M
ENTA icon
65
Enanta Pharmaceuticals
ENTA
$400M
$19.1M 0.09%
2,025,000
+150,000
+8% +$1.4M
ZYME icon
66
Zymeworks
ZYME
$1.67B
$18.2M 0.08%
1,756,000
-244,000
-12% -$1.94M
TAL icon
67
TAL Education Group
TAL
$6.87B
$17.2M 0.08%
1,365,000
– –
SIMO icon
68
Silicon Motion
SIMO
$8.68B
$15.1M 0.07%
246,500
-798,500
-76% -$45.7M
IMVT icon
69
Immunovant
IMVT
$8.25B
$14.4M 0.07%
341,000
-163,000
-32% -$6M
LNTH icon
70
Lantheus
LNTH
$6.59B
$13.2M 0.06%
213,327
-1,385,173
-87% -$93.9M
VYGR icon
71
Voyager Therapeutics
VYGR
$201M
$10.9M 0.05%
1,292,000
– –
SCRM
72
DELISTED
Screaming Eagle Acquisition Corp. Class A Ordinary Shares
SCRM
$10.6M 0.05%
1,000,000
– –
RIO icon
73
Rio Tinto
RIO
$164B
$10.2M 0.05%
137,500
– –
TVTX icon
74
Travere Therapeutics
TVTX
$5.78B
$9.84M 0.05%
1,094,000
+822,483
+303% +$5.99M
NBIX icon
75
Neurocrine Biosciences
NBIX
$16.6B
$9.54M 0.04%
72,398
-375,602
-84% -$43.2M
1 2
3
4 5

Similar funds

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
MCM
MAI Capital Management Independence, Ohio $17.7B AUM 18.87% 1-Year Est. Return
LA
Linden Advisors New York $17.9B AUM 1.72% 1-Year Est. Return
CM
Caption Management Oklahoma City, Oklahoma $17.1B AUM 70.99% 1-Year Est. Return
ASRS
Arizona State Retirement System Phoenix, Arizona $17.1B AUM 30.52% 1-Year Est. Return
PP
Prudential plc London, England, United Kingdom $17.1B AUM 15.7% 1-Year Est. Return
VMPIC
Varma Mutual Pension Insurance Co Helsinki, Finland $17B AUM 24.09% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Farallon Capital Management's Q4 2023 Portfolio in Review

As of Q4 2023, Farallon Capital Management held 190 positions worth $21.9B, up 2% from $21.4B the previous quarter. Its ten largest holdings account for 52% of the portfolio.

Farallon Capital Management withdrew a net $2.03B in Q4 2023, closing 32 positions and reducing 39 holdings. Its most notable exit was Activision Blizzard, an estimated $1.9B position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 27% of assets, down from 31% a quarter earlier, followed by Technology and Financials.

Against the trend, Farallon Capital Management opened a new position in Pioneer Natural Resource Co. worth $702M.

  • Farallon Capital Management's largest Q4 2023 buy was Pioneer Natural Resource Co.: 3,120,000 shares worth $702M.
  • Farallon Capital Management added most to Nasdaq in Q4 2023, an estimated $341M increase.
  • Farallon Capital Management's biggest Q4 2023 reduction was AstraZeneca, cutting an estimated $145M.
  • Farallon Capital Management fully exited Activision Blizzard in Q4 2023, selling an estimated $1.9B.
  • Farallon Capital Management's ten largest holdings make up 52% of its $21.9B portfolio in Q4 2023.
  • Farallon Capital Management opened 27 new positions and closed 32 in Q4 2023.
  • Farallon Capital Management's portfolio value rose 2% quarter-over-quarter to $21.9B.

Based on Farallon Capital Management's 13F filing for Q4 2023, filed 14 Feb 2024.